Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schwabl

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Temporal and spatial dynamics of <i>Plasmodium falciparum</i> clonal lineages in GuyanaMathieu Vanhove, Philipp Schwabl, Colette Clementson, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.
Journal of Personalized Medicine|April 30, 2021
Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVRGeorg Semmler, Teresa Binter, Karin Kozbial, et al.
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Temporal and spatial dynamics of <i>Plasmodium falciparum</i> clonal lineages in GuyanaMathieu Vanhove, Philipp Schwabl, Colette Clementson, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Plos One|September 30, 2014
PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertensionChristian Jansen, Diana J Leeming, Mattias Mandorfer, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Pageof 32